Reuters logo
BRIEF-Abivax receives approval to begin clinical trial of ABX464
September 20, 2017 / 6:08 AM / 2 months ago

BRIEF-Abivax receives approval to begin clinical trial of ABX464

Sept 20 (Reuters) - ABIVAX SA:

* ABIVAX RECEIVES FRENCH REGULATORY APPROVAL TO BEGIN CLINICAL TRIAL OF ABX464 IN ULCERATIVE COLITIS

* INITIATING STUDY IN Q4 OF 2017

* ANNOUNCED THAT FRENCH NATIONAL REGULATORY AUTHORITY (ANSM) HAS APPROVED ABX464-101 PHASE 2A “PROOF-OF-CONCEPT” STUDY

* AND EXPECT TOP-LINE DATA IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below